Opus Genetics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-5.1M | $-5.1M | — | $497.5K |
| FY2010 | $-7.0M | $-7.0M | — | $584.7K |
| FY2011 | $-15.5M | $-15.5M | — | $638.6K |
| FY2012 | $-6.6M | $-6.6M | — | $231.0K |
| FY2013 | $-8.0M | $-8.0M | — | $565.4K |
| FY2014 | $-11.0M | $-11.0M | — | $608.8K |
| FY2015 | $-17.4M | $-17.4M | — | $1.0M |
| FY2016 | $-13.2M | $-13.2M | — | $1.4M |
| FY2017 | $-15.4M | $-15.4M | — | $1.0M |
| FY2018 | $-18.8M | $-18.8M | — | $1.2M |
| FY2019 | $-3.6M | $-3.6M | $25.0K | $308.0K |
| FY2020 | $-6.8M | $-6.8M | $0 | $1.5M |
| FY2021 | $-19.4M | $-19.4M | — | $1.9M |
| FY2022 | $14.3M | $14.3M | — | $1.8M |
| FY2023 | $-1.1M | $-1.1M | — | $3.5M |
| FY2024 | $-25.6M | $-25.6M | — | $3.4M |
| FY2025 | $-35.3M | $-35.3M | — | $3.4M |